Eli Lilly and Co told the Securitiesand Exchange Commission it cut its stake in Liposome Co Inc to500,000 shares, or 4.0 pct of the total outstanding commonstock, from 900,000 shares or 7.3 pct.    Lilly said it sold 400,000 Liposome common shares on March17 at eight dlrs each.    As long as Lilly's stake in Liposome is below five pct, itis not required to report any further dealings it has in thecompany's stock. Reuter&#3;